Oruka Therapeutics Q3 EPS $(0.63) Misses $(0.60) Estimate

Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.60) by 5 percent. This is a 14.55 percent decrease over losses of $(0.55) per share from the same period last year.